These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31102833)

  • 1. Generation of refractory schizophrenia patient-derived induced pluripotent stem cell line UJSi001-A.
    Sun J; Zhang X; Cong Q; Wang C; Chen D; Wang Y; Wang X; Yi Z; Qin S
    Stem Cell Res; 2019 Jul; 38():101460. PubMed ID: 31102833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of ultra-treatment-resistant schizophrenia patient-derived induced pluripotent stem cell line UJSi002-A.
    Sun J; Zeng R; Liu Y; Xi S; Sun T; Qian J; Yi Z; Qin S
    Stem Cell Res; 2022 May; 61():102766. PubMed ID: 35367693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.A11.
    Hansen SK; Borland H; Hasholt LF; Tümer Z; Nielsen JE; Rasmussen MA; Nielsen TT; Stummann TC; Fog K; Hyttel P
    Stem Cell Res; 2016 May; 16(3):553-6. PubMed ID: 27346190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and characterization of an induced pluripotent stem cell (iPSC) line from a patient with clozapine-resistant Schizophrenia.
    Marsoner F; Marcatili M; Karnavas T; Bottai D; D'Agostino A; Scarone S; Conti L
    Stem Cell Res; 2016 Nov; 17(3):661-664. PubMed ID: 27934603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of an induced pluripotent stem cell line from a congenital microtia patient with 4p16.1 microduplication involving the long-range enhancer of HMX1.
    Si N; Zhang Z; Meng X; Huang X; Wang C; Pan B
    Stem Cell Res; 2021 May; 53():102357. PubMed ID: 34087987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease.
    Wang Y; Wang Z; Sun H; Mao C; Yang J; Liu Y; Liu H; Zhang S; Zhang J; Xu Y; Shi C
    Stem Cell Res; 2018 Oct; 32():87-90. PubMed ID: 30237140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of an induced pluripotent stem cell (iPSC) line from a patient with Clozapine-responder Schizophrenia.
    Marcatili M; Marsoner F; D'Agostino A; Karnavas T; Bottai D; Scarone S; Conti L
    Stem Cell Res; 2016 Nov; 17(3):630-633. PubMed ID: 27934596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of induced pluripotent stem cell (iPSC) line from a 36-year-old Charcot-Marie-Tooth disease patient with GJB1 mutation (CMTX).
    Son D; Kang PJ; Yun W; You S
    Stem Cell Res; 2017 May; 21():9-12. PubMed ID: 28677541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
    Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Episomal plasmid-based generation of an iPSC line from an 83-year-old individual carrying the APOE4/4 genotype: i10984.
    Zulfiqar S; Fritz B; Nieweg K
    Stem Cell Res; 2016 Nov; 17(3):523-525. PubMed ID: 27789402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a L150P mutation in PSEN-1.
    Tubsuwan A; Pires C; Rasmussen MA; Schmid B; Nielsen JE; Hjermind LE; Hall V; Nielsen TT; Waldemar G; Hyttel P; Clausen C; Kitiyanant N; Freude KK; Holst B
    Stem Cell Res; 2016 Jan; 16(1):110-2. PubMed ID: 27345792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced pluripotent stem cells (iPSCs) derived from cerebrotendinous xanthomatosis (CTX) patient's fibroblasts carrying a R395S mutation.
    Höflinger P; Hauser S; Theurer Y; Weißenberger S; Wilke C; Schöls L
    Stem Cell Res; 2016 Sep; 17(2):433-436. PubMed ID: 27879219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Construction and Identification of Induced Pluripotent Stem Cells Derived from Acute Myelogenous Leukemia Cells.
    Zhu LF; Chen QR; Chen SZ; Wang LY; Luo XF; Ren JH; Yuan XH; Wu XQ; Zeng YL; Xiao M; Chen YQ; Chen YY; Lin MH; Wu ZJ; Chen ZZ; Hu JD; Yang T
    Cell Physiol Biochem; 2017; 41(4):1661-1674. PubMed ID: 28359056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Episomal plasmid-based generation of an iPSC line from a 79-year-old individual carrying the APOE4/4 genotype: i11001.
    Zulfiqar S; Fritz B; Nieweg K
    Stem Cell Res; 2016 Nov; 17(3):544-546. PubMed ID: 27789405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of human-induced pluripotent stem cells (hiPSCs) using episomal vectors on defined Essential 8™ Medium conditions.
    Fontes A; Macarthur CC; Lieu PT; Vemuri MC
    Methods Mol Biol; 2013; 997():57-72. PubMed ID: 23546748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of induced pluripotent stem cell line, ICGi007-A, by reprogramming peripheral blood mononuclear cells from a patient with Huntington's disease.
    Grigor'eva EV; Malankhanova TB; Surumbayeva A; Minina JM; Morozov VV; Abramycheva NY; Illarioshkin SN; Malakhova AA; Zakian SM
    Stem Cell Res; 2019 Jan; 34():101382. PubMed ID: 30658253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids.
    Meraviglia V; Zanon A; Lavdas AA; Schwienbacher C; Silipigni R; Di Segni M; Chen HS; Pramstaller PP; Hicks AA; Rossini A
    J Vis Exp; 2015 Jun; (100):e52885. PubMed ID: 26131963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of three control iPS cell lines for sickle cell disease studies by reprogramming erythroblasts from individuals without hemoglobinopathies.
    Paredes BD; Martins GLS; Azevedo CM; Sampaio GLA; Nonaka CKV; Silva KND; Soares MBP; Santos RRD; Souza BSF
    Stem Cell Res; 2019 Jul; 38():101454. PubMed ID: 31078962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying an A79V mutation in PSEN1.
    Li T; Pires C; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Dinnyes A; Hyttel P; Freude KK
    Stem Cell Res; 2016 Mar; 16(2):229-32. PubMed ID: 27345973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.